PHARMACIA CORP /DE/
10-Q, EX-27, 2000-08-14
CHEMICALS & ALLIED PRODUCTS
Previous: PHARMACIA CORP /DE/, 10-Q, 2000-08-14
Next: MONTANA POWER CO /MT/, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                           1,199
<SECURITIES>                                         0
<RECEIVABLES>                                    5,984
<ALLOWANCES>                                       290
<INVENTORY>                                      2,658
<CURRENT-ASSETS>                                11,495
<PP&E>                                          12,199
<DEPRECIATION>                                   5,223
<TOTAL-ASSETS>                                  27,182
<CURRENT-LIABILITIES>                            7,495
<BONDS>                                          5,005<F1>
                                0
                                        269
<COMMON>                                         2,937
<OTHER-SE>                                       8,572
<TOTAL-LIABILITY-AND-EQUITY>                    27,182
<SALES>                                          9,322
<TOTAL-REVENUES>                                 9,322
<CGS>                                            2,915
<TOTAL-COSTS>                                    2,915
<OTHER-EXPENSES>                                 1,421<F2>
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 201
<INCOME-PRETAX>                                    740
<INCOME-TAX>                                       262
<INCOME-CONTINUING>                                478
<DISCONTINUED>                                     (1)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       477
<EPS-BASIC>                                       0.37
<EPS-DILUTED>                                     0.36
<FN>
<F1>Includes guarantee of ESOP debt.
<F2>Only includes R&D expense.
</FN>


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission